Prevalence of chronic airflow limitation in Kashmir, North India: Results from the BOLD study

International Journal of Tuberculosis and Lung Disease

Volumn 20, Issue 10, 2016, Pages 1399-1404

  Koul, Parvaiz A ^a   Hakim, N A ^a   Malik, S A ^a   Khan, U H ^a   Patel, J ^b   Gnatiuc, L ^b   Burney, P G J ^c  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic airflow limitation; COPD; Prevalence; Smoking; Spirometry

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COOKING; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SPIROMETRY; WOOD; CHRONIC DISEASE; MIDDLE AGED; VITAL CAPACITY; WATER PIPE SMOKING;

ADULT; AGED; CHRONIC DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INDIA; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; VITAL CAPACITY; WATER PIPE SMOKING;

EID: 84987642049     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0968     Document Type: Article

References (39)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013; 380: 2095-2128.
2. Mannino D M, Gagnon R C, Petty T L, Lydick E. Obstructive lung disease and low lung function in adults in the United States. Arch Intern Med 2000; 160: 1683-1689.
3. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004; 9: 458-465.
4. Kim D S, Kim Y S, Chung K S, et al. Korean Academy of Tuberculosis and Respiratory Diseases. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005; 172: 842-847.
5. Peña V S, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC Multicentre Epidemiological Study. Chest 2000; 118: 981-989.
6. Halbert R J, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003; 123: 1684-1692.
7. Halbert R J, Natoli J L, Gano A, Badamgarav E, Buist A S, Mannino D M. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532.
8. Salve S, Agarwal A. India needs a national COPD prevention and control program. J Assoc Physicians India 2012; 60 (Suppl): 5-7.
9. Jindal S K, Aggarwal A N, Gupta D. A review of population studies from India to estimate national burden of chronic obstructive pulmonary disease and its association with smoking. Indian J Chest Dis Allied Sci 2001; 43: 139-146.
10. Jindal S K, Aggarwal A N, Gupta D, et al. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 2012; 16: 1270-1277.
11. Burney P, Jithoo A, Kato B, et al. Burden of Obstructive Lung Disease (BOLD) Study. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty - a BOLD analysis. Thorax 2014; 69: 465-473.
12. Koul P A. Chronic obstructive pulmonary disease: Indian guidelines and beyond. Lung India 2013; 30: 175-177.
13. Buist A S, Vollmer W M, Sullivan S D, et al. The Burden of Obstructive Lung Disease initiative (BOLD): rationale and design. J COPD 2005; 2: 277-283.
14. Enright P, Vollmer W M, Lamprecht B, et al. Quality of spirometry tests performed by 9893 adults in 14 countries: the BOLD Study. Respir Med 2011; 105: 1507-1515.
15. Ware J Jr, Kosinski M, Keller S D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
16. American Thoracic Society Statement. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
17. Hankinson J, Eschenbacher B, Townsend M, Stocks J, Quanjer P. Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test. Eur Respir J. 2015; 45: 1283-1292.
18. Hankinson J L, Odencrantz J R, Fedan K B. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187.
19. Masters N, Tutt C. Smoking pack year calculator 2007. Hazlemere, UK: Smoking Pack Years, 2007-2013. http://smokingpackyears.com/. Accessed June 2016.
20. Lohr S L. Sampling: design and analysis. Pacific Grove, CA, USA: Duxbury Press Publishing Company, 1999: pp 268-269.
21. Qureshi K A. Domestic smoke pollution and prevalence of chronic bronchitis/asthma in a rural area of Kashmir. Indian J Chest Dis Allied Sci 1994: 362: 61-72.
22. Koul P A, Hajni M R, Sheikh M A, et al. Hookah smoking and lung cancer in the Kashmir Valley of Indian subcontinent. Asian Pac J Cancer Prev 2011; 12: 519-524.
23. Koul P A, Chaouachi K. Important clarifications about peculiarities of hookah smoking and lung cancer in Kashmir. Asian Pac J Cancer Prev 2011; 12: 2145-2146.
24. Salvi S, Barnes P. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374: 733-743.
25. Hooper R, Burney P, Vollmer W, et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J 2012; 39: 1343-1353.
26. Smith M, Li L, Augustyn M, et al. Prevalence and correlates of airflow obstruction in 317,000 never-smokers in China. Eur Respir J 2014; 44: 66-77.
27. United Nations Development Programme. Addressing the social determinants of non-communicable disease. New York, NY, USA: UNDP, 2013. http://www.undp.org/content/dam/undp/library/hivaids/English/Discussion-Paper-Addressing-the-Social-Determinants-of-NCDs-UNDP-2013.pdf. Accessed June 2016.
28. Reich D, Thangaraj K, Patterson N, Price A L, Singh L. Reconstructing Indian population history. Nature 2009; 24; 461: 489-494.
29. International Institute for Population Sciences (IIPS), Harvard School of Public Health, and RAND Corporation, USA. Longitudinal ageing study in India (LASI-Pilot survey), 2010. Noida, India: IIPS, 2010: p 25.
30. Mahal A, Karan A, Engelgau M. The economic implications of non-communicable disease for India. Washington DC, USA: The International Bank for Reconstruction and Development/The World Bank, 2009: p xiv.
31. Reddy K S, Mohan S. Chronic diseases in India: burden and implications. Swiss Re Center for Global Dialogue. Rüschlikon, Switzerland: Swiss Re, 2014, http://cgd.swissre.com/global-dialogue/topics/Cardiovascular-risks-in-HGM/Chronic-Diseases-in-IndiaBurden-and-Implications.html. Accessed June 2016.
32. Indian Council of Medical Research-Medical Research Council Workshop. Building Indo-UK collaboration in chronic diseases. New Delhi, India: ICMR, 2009: p 16.
33. Lopez A D, Shibuya K, Rao C, et al. Chronic obstructive airway disease: current burden and future projections. Eur Respir J 2006; 27: 397-412.
34. Rossiter C E, Weill H. Ethnic differences in lung function: evidence for proportional differences. Int J Epidemiol 1974; 3: 55-61.
35. Vaz Fragoso C A, McAvay G, Van Ness P H, et al. Phenotype of spirometric impairment in and aging population. Am J Respir Crit Care Med 2016; 193: 727-735.
36. Pauwels R A, Buist A S, Calverley P M A, Jenkins C R, Hurd S S. The GOLD Scientific Committee: global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1256-1276.
37. Hooper R, Burney P. Cross-sectional relation of ethnicity to ventilatory function in a West London population. Int J Tuberc Lung Dis 2013; 17: 400-405.
38. Gnatiuc L, Buist A S, Kato B, et al. Gaps in using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites. Int J Tuberc Lung Dis 2015; 19: 21-30.
39. Koul P A. Managing chronic diseases: combination of inhaler treatment in India has shown good results. BMJ 2005; 330: 964.